Antihypertensive Drugs and the Risk of Congenital Anomalies
Author:
Affiliation:
1. Department of Epidemiology; Boston University School of Public Health; Boston; Massachusetts
2. Boston Collaborative Drug Surveillance Program; Boston University School of Medicine; Lexington; Massachusetts
Publisher
Wiley
Subject
Pharmacology (medical)
Reference23 articles.
1. Hypertension in pregnancy: diagnosis and treatment;Garovic;Mayo Clin Proc,2000
2. ACE inhibitors and congenital anomalies;Friedman;N Engl J Med,2006
3. Major congenital malformations after first-trimester exposure to ACE inhibitors;Cooper;N Engl J Med,2006
4. Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy-United States, Canada and Israel, 1987-1995;Centers for Disease Control and Prevention;JAMA,1997
5. Risks of angiotensin-converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use;Shotan;Am J Med,1994
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Specialty grand challenge editorial innovative approaches for pharmacoepidemiologic research in pregnancy: Shifting the paradigm of Thalidomide’s impact on pregnant women;Frontiers in Drug Safety and Regulation;2023-03-31
2. Maternal and neonatal outcomes associated with treating hypertension in pregnancy at different thresholds;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2023-02-23
3. The identification and validity of congenital malformation diagnoses in UK electronic health records: A systematic review;Pharmacoepidemiology and Drug Safety;2021-05-04
4. Increased risk of major congenital malformations in early pregnancy use of angiotensin‐converting‐enzyme inhibitors and angiotensin‐receptor‐blockers: a meta‐analysis;Diabetes/Metabolism Research and Reviews;2021-04-13
5. Risk of congenital malformations in offspring of women using β‐blockers during early pregnancy: An updated meta‐analysis of observational studies;British Journal of Clinical Pharmacology;2020-10-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3